CBO estimates major impacts from House Dem drug price negotiation bill:
— Loren Adler (@LorenAdler) October 12, 2019
- ↓ deficits by $345B over 7 yrs
- ↓ US prices for negotiated drugs by 40-55%, on avg
- 8 to 15 fewer new drugs to mrkt over next 10 yrs
- Large savings for consumershttps://t.co/lRGNjjAi0O pic.twitter.com/RZMCH2MdIv